Abstract
The study of isatin, as well as its kind of derivatives, has become a hot topic for a long time. To explore the new compounds and bioactivities, in this work, a series of simple isatin Mannich and Schiff bases was synthesized through the condensation reaction. The structures of these synthesized compounds were characterized using NMR and MS. Furthermore, structure of one of these compounds (IMS-4) was studied by using single crystal X-ray diffraction. Then the anti-tumor and neuro-protection activities of these compounds were evaluated. The results showed that several compounds show protection activity on the PC12 cells apoptosis induced by H2O2, which are more effective than that of (±) α-Tocophreol (VE). Besides, some compounds also show anti-tumor activity against A549 and P388 cell lines more potent than that of isatin.
Keywords: Isatin, mannich base, schiff base, synthesis, neuro-protection, anti-tumor.
Letters in Drug Design & Discovery
Title:Synthesis, Neuro-protection and Anti-cancer Activities of Simple Isatin Mannich and Schiff Bases
Volume: 13 Issue: 5
Author(s): Gang Chen, Yang Ning, Wei Zhao, Yanqiu Zhang, Yu Zhang, Xiaojiang Hao, Ye Wang and Shuzhen Mu
Affiliation:
Keywords: Isatin, mannich base, schiff base, synthesis, neuro-protection, anti-tumor.
Abstract: The study of isatin, as well as its kind of derivatives, has become a hot topic for a long time. To explore the new compounds and bioactivities, in this work, a series of simple isatin Mannich and Schiff bases was synthesized through the condensation reaction. The structures of these synthesized compounds were characterized using NMR and MS. Furthermore, structure of one of these compounds (IMS-4) was studied by using single crystal X-ray diffraction. Then the anti-tumor and neuro-protection activities of these compounds were evaluated. The results showed that several compounds show protection activity on the PC12 cells apoptosis induced by H2O2, which are more effective than that of (±) α-Tocophreol (VE). Besides, some compounds also show anti-tumor activity against A549 and P388 cell lines more potent than that of isatin.
Export Options
About this article
Cite this article as:
Chen Gang, Ning Yang, Zhao Wei, Zhang Yanqiu, Zhang Yu, Hao Xiaojiang, Wang Ye and Mu Shuzhen, Synthesis, Neuro-protection and Anti-cancer Activities of Simple Isatin Mannich and Schiff Bases, Letters in Drug Design & Discovery 2016; 13 (5) . https://dx.doi.org/10.2174/1570180812666150907203342
DOI https://dx.doi.org/10.2174/1570180812666150907203342 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Amrubicin: A Synthetic Anthracyclin Analogue in the Treatment of Extensive Stage Small Cell Lung Cancer
Recent Patents on Anti-Cancer Drug Discovery Clinical Development of MET Targeted Therapy For Human Cancer
Current Cancer Therapy Reviews Recent Advances in Phenanthroindolizidine and Phenanthroquinolizidine Derivatives with Anticancer Activities
Anti-Cancer Agents in Medicinal Chemistry Do We have the Evidence to Repurpose Levamisole for Treatment of COVID 19?
Current Drug Therapy Clinical Significance of Mesothelin in Pancreatic Cancer
Current Signal Transduction Therapy Meet Our Editorial Board Member:
Protein & Peptide Letters Multifunctional Radiolabeled Nanoparticles for Targeted Therapy
Current Medicinal Chemistry Hypoxia-Inducible Factor 1 in Tumor Radioresistance
Current Signal Transduction Therapy Vascular Endothelial Growth Factor (VEGF) as a Target of Bevacizumab in Cancer: From the Biology to the Clinic
Current Medicinal Chemistry Urokinase Receptor (uPAR) Ligand based Recombinant Toxins for Human Cancer Therapy
Current Pharmaceutical Design Rikkunshito and Ghrelin Secretion
Current Pharmaceutical Design True Antisense Oligonucleotides with Modified Nucleotides Restricted in the Nconformation
Current Topics in Medicinal Chemistry 4-Methylumbelliferones Analogues as Anticancer Agents: Synthesis and in Cell Pharmacological Studies
Anti-Cancer Agents in Medicinal Chemistry Selected Approaches for Rational Drug Design and High Throughput Screening to Identify Anti-Cancer Molecules
Anti-Cancer Agents in Medicinal Chemistry Natural Products in Structure-Assisted Design of Molecular Cancer Therapeutics
Current Pharmaceutical Design A Potential Anticancer Agent 1,2-di(quinazolin-4-yl)diselane
Letters in Drug Design & Discovery MicroRNA-16-5p Controls Development of Osteoarthritis by Targeting SMAD3 in Chondrocytes
Current Pharmaceutical Design Recent Developments in Targeting Bromodomain and Extra Terminal Domain Proteins for Cancer Therapeutics
Current Medicinal Chemistry Distribution and Characteristics of Intrathoracic Lymphadenopathy in TB/HIV Co-Infection
Infectious Disorders - Drug Targets A Structure-Function Perspective of Jak2 Mutations and Implications for Alternate Drug Design Strategies: The Road not Taken
Current Medicinal Chemistry